Dr Esme Hill
BSc, MBChB, MSc, MRCP, FRCR, DPhil Radiobiology, Clinical Oncologist
Languages spoken
English
Expert in
Upper GI
Overview
Dr Hill is the Clinical Lead for malignant spinal cord compression at the Royal Berkshire Hospital as well as an Educational Supervisor for Core Medical Trainees. She is a core member of the upper GI cancer multidisciplinary team at the Royal Berkshire and Wexham Park Hospitals and has strong working relationships with the Oxford oesophagogastric and hepato-biliary teams. She has a special clinical interest in upper GI, liver cancer and pancreatic cancer.
Dr Hill is co-investigator for the ADD-ASPIRIN trial and principal investigator (PI) for the SCOPE-2 trial. She has a significant portfolio of published work and has received several awards for her research.
.svg){kind=icon}
Career positions
Current position(s)
- Consultant Oncologist and Clinical Lead, Royal Berkshire and Wexham Park Hospitals
- Clinical Lead for malignant spinal cord compression at the Royal Berkshire Hospital
- Educational Supervisor for Core Medical Trainees.
Year qualified
- 2001
Expertise and interests
Interests
- Upper GI, liver cancer and pancreatic cancer
Accomplishments
Awards received
- Royal College of Radiologists Ross Prize for best proffered paper at the National Cancer Research Institute Conference in Liverpool (2013)
- British Association of Cancer Research Travel Award for high quality abstract submission to the BACR conference (2013)